As shown in Figure 4, nearly 18% of clinical breast invasive carcinoma samples in TCGA database had shown high amplification of the genomic region that harbored ERBB2, GRB7 and other neighboring genes. This evidence concerns the gene GRB7 and invasive breast carcinoma.